Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria

Allergol Int. 2020 Apr;69(2):304-306. doi: 10.1016/j.alit.2019.10.009. Epub 2019 Nov 23.

¹ Department of Dermatology, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea; Allergy and Clinical Immunology Research Center, Hallym University College of Medicine, Chuncheon, South Korea.
² Allergy and Clinical Immunology Research Center, Hallym University College of Medicine, Chuncheon, South Korea; Hallym University College of Medicine, Graduate School, Chuncheon, South Korea.
³ Department of Emergency Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea.
⁴ Allergy and Clinical Immunology Research Center, Hallym University College of Medicine, Chuncheon, South Korea; Department of Pulmonology and Allergy, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea. Electronic address: mdqueen@hallym.or.kr.

No abstract available

Publication types